Profile data is unavailable for this security.
About the company
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
- Revenue in USD (TTM)13.64bn
- Net income in USD721.80m
- Incorporated1994
- Employees78.00k
- LocationDaVita Inc2000 16th StDENVER 80202-5158United StatesUSA
- Phone+1 (310) 536-2668
- Fax+1 (302) 636-5454
- Websitehttps://www.davita.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemed Corp | 2.53bn | 265.24m | 5.80bn | 15.81k | 22.93 | 5.90 | 17.57 | 2.29 | 18.38 | 18.38 | 174.89 | 71.43 | 1.58 | 216.93 | 14.30 | 160,013.80 | 16.54 | 17.85 | 20.14 | 22.20 | 32.54 | 34.88 | 10.48 | 11.81 | 1.03 | -- | 0.0111 | 9.30 | 4.06 | 4.00 | -12.17 | -3.65 | 1.31 | 10.76 |
| Radnet Inc | 1.97bn | -12.71m | 5.82bn | 8.55k | -- | 5.47 | 34.51 | 2.96 | -0.1828 | -0.1828 | 25.53 | 13.74 | 0.5676 | -- | 8.71 | 230,470.30 | 0.617 | 1.20 | 0.7907 | 1.59 | 21.33 | 22.02 | 1.09 | 1.90 | -- | 1.32 | 0.4549 | 0.00 | 13.18 | 9.65 | -8.25 | -28.32 | 20.46 | -- |
| PACS Group Inc | 5.14bn | 169.04m | 5.94bn | 45.68k | 36.55 | 6.79 | 26.87 | 1.16 | 1.03 | 1.03 | 31.45 | 5.56 | 1.01 | -- | 8.54 | 112,496.50 | 3.31 | -- | 4.07 | -- | 21.38 | -- | 3.27 | -- | -- | 12.19 | 0.3813 | -- | 31.44 | -- | -50.60 | -- | -- | -- |
| Molina Healthcare Inc | 45.43bn | 472.00m | 7.85bn | 19.00k | 17.86 | 1.91 | 11.77 | 0.1728 | 8.54 | 8.54 | 858.31 | 79.78 | 2.91 | -- | 13.19 | 2,390,842.00 | 3.03 | 6.20 | 5.93 | 13.33 | 13.07 | 14.69 | 1.04 | 2.33 | -- | 4.08 | 0.4926 | 0.00 | 11.75 | 18.52 | -59.97 | -6.85 | 6.42 | -- |
| Brightspring Health Services Inc | 12.91bn | 106.35m | 8.05bn | 23.50k | 86.05 | 4.26 | 29.91 | 0.6233 | 0.4832 | 0.8688 | 59.17 | 9.76 | 2.09 | 15.65 | 12.79 | 549,385.70 | 1.70 | -0.5355 | 2.32 | -0.6793 | 11.76 | 14.47 | 0.8117 | -0.3312 | 1.12 | 2.51 | 0.5728 | -- | 28.18 | 18.27 | 259.99 | 38.58 | 12.96 | -- |
| Davita Inc | 13.64bn | 721.80m | 10.29bn | 78.00k | 16.11 | -- | 5.81 | 0.7539 | 9.56 | 9.91 | 179.74 | -9.50 | 0.7849 | 62.63 | 5.98 | 174,911.10 | 6.06 | 6.13 | 8.47 | 8.24 | 32.25 | 31.51 | 7.72 | 8.48 | 1.24 | 3.77 | 0.8987 | -- | 6.46 | 3.39 | -22.91 | -1.62 | -3.11 | -- |
| Encompass Health Corp | 5.94bn | 565.70m | 10.74bn | 24.61k | 19.51 | 4.43 | 9.87 | 1.81 | 5.54 | 5.53 | 58.10 | 24.38 | 0.8713 | -- | 9.75 | 241,160.50 | 11.16 | 8.11 | 14.72 | 10.27 | 95.71 | 95.51 | 12.81 | 10.58 | -- | 8.88 | 0.4319 | 19.06 | 10.46 | 10.72 | 24.14 | 23.88 | 12.52 | -8.46 |
| Ensign Group Inc | 5.06bn | 343.97m | 12.54bn | 46.00k | 36.94 | 5.62 | 27.96 | 2.48 | 5.84 | 5.84 | 85.94 | 38.42 | 0.9984 | -- | 8.38 | 109,953.10 | 6.80 | 6.66 | 8.11 | 8.05 | 21.07 | 21.89 | 6.81 | 6.82 | -- | -- | 0.0597 | 5.16 | 18.72 | 16.05 | 15.44 | 15.07 | 20.77 | 4.77 |
| Universal Health Services Inc | 17.36bn | 1.49bn | 12.61bn | 88.10k | 8.92 | 1.73 | 5.92 | 0.7262 | 23.15 | 23.15 | 269.38 | 119.15 | 1.16 | -- | 7.27 | 197,103.60 | 10.08 | 7.25 | 12.43 | 8.67 | -- | -- | 8.70 | 6.85 | 0.9803 | 12.43 | 0.3908 | 5.70 | 9.71 | 8.48 | 30.36 | 9.61 | 6.69 | 31.95 |
| Holder | Shares | % Held |
|---|---|---|
| Berkshire Hathaway, Inc. (Investment Management)as of 29 Jan 2026 | 30.10m | 42.64% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 3.83m | 5.43% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 2.19m | 3.11% |
| Invesco Capital Management LLCas of 31 Dec 2025 | 1.67m | 2.37% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 1.44m | 2.04% |
| Arrowstreet Capital LPas of 31 Dec 2025 | 1.19m | 1.69% |
| Gates Capital Management, Inc.as of 31 Dec 2025 | 1.18m | 1.67% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 990.33k | 1.40% |
| Geode Capital Management LLCas of 31 Dec 2025 | 978.79k | 1.39% |
| LSV Asset Managementas of 31 Dec 2025 | 936.77k | 1.33% |
